Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices
Kátia Roque, Rossana Ruiz, Luís Más, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4547-4547
Open Access | Times Cited: 9

Showing 9 citing articles:

[Translated article] Relationship between lactate dehydrogenase and survival in patients with non-small-cell lung cancer receiving immunotherapy
Claudia Rosique-Aznar, Alejandro Valcuende-Rosique, D Rosique-Robles, et al.
Farmacia Hospitalaria (2025)
Open Access | Times Cited: 1
Exploring manzamine a: a promising anti-lung cancer agent from marine sponge Haliclona sp
Su Min, Jie Zhu, Lu Bai, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Role of Epiregulin in Lung Tumorigenesis and Therapeutic Resistance
Noriaki Sunaga, Yosuke Miura, Tomomi Masuda, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 710-710
Open Access | Times Cited: 1
Clinical efficacy and potential mechanism of ginseng polysaccharides in the treatment of non-small cell lung cancer based on meta-analysis associated with network pharmacology
Qi Zhao, Le Bai, Dongwei Zhu, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27152-e27152
Open Access | Times Cited: 1
Healthcare Resource Utilization and Associated Costs among Patients with Advanced Non-Small-Cell Lung Cancer Receiving Chemotherapy or Immunotherapy in Spain: A Single-Center, Real-World, Exploratory Study
Jorge Ginés Rubió, Olga Delgado Sánchez, Angel Callejo, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2068-2068
Open Access | Times Cited: 1
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”
Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2877-2877
Open Access | Times Cited: 1
Relación entre el lactato deshidrogenasa y la supervivencia en pacientes con cáncer de pulmón no microcítico que reciben tratamiento con inmunoterapia
Claudia Rosique-Aznar, Alejandro Valcuende-Rosique, D Rosique-Robles, et al.
Farmacia Hospitalaria (2024)
Open Access
Germline HLA status is associated with immunotherapy-induced pneumonitis and treatment response in non-small cell lung carcinoma patients with high PD-L1 expression
Any Cheung, Zeta Mui, Walter Wai Yeung, et al.
JTO Clinical and Research Reports (2024) Vol. 6, Iss. 1, pp. 100754-100754
Open Access
Addressing the unmet need in NSCLC progression with advances in second-line therapeutics
Kaige Wang, Alexis Leyba, Robert Hsu
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 6, pp. 1297-1320
Open Access
Page 1

Scroll to top